Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Prediction of Survival With Long-Term Disease Progression in Most Common Spinocerebellar Ataxia.

Diallo A, Jacobi H, Cook A, Giunti P, Parkinson MH, Labrum R, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Castaldo A, Rakowicz M, Rola R, Sulek A, Schmitz-Hübsch T, Schöls L, Hengel H, Baliko L, Melegh B, Filla A, Antenora A, Infante J, Berciano J, van de Warrenburg BP, Timmann D, Boesch S, Nachbauer W, Pandolfo M, Schulz JB, Bauer P, Jun-Suk K, Klockgether T, Tezenas du Montcel S.

Mov Disord. 2019 Aug;34(8):1220-1227. doi: 10.1002/mds.27739. Epub 2019 Jun 18.

PMID:
31211461
2.

Erythropoietin and Friedreich Ataxia: Time for a Reappraisal?

Boesch S, Indelicato E.

Front Neurosci. 2019 Apr 24;13:386. doi: 10.3389/fnins.2019.00386. eCollection 2019. Review.

3.

Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis.

Krismer F, Seppi K, Göbel G, Steiger R, Zucal I, Boesch S, Gizewski ER, Wenning GK, Poewe W, Scherfler C.

Mov Disord. 2019 Jul;34(7):1041-1048. doi: 10.1002/mds.27669. Epub 2019 Mar 28.

PMID:
30919495
4.

Patient-reported outcomes in Friedreich's ataxia after withdrawal from idebenone.

Cook A, Boesch S, Heck S, Brunt E, Klockgether T, Schöls L, Schulz A, Giunti P.

Acta Neurol Scand. 2019 Jun;139(6):533-539. doi: 10.1111/ane.13088. Epub 2019 Apr 8.

PMID:
30887496
5.

Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia.

Lynch DR, Farmer J, Hauser L, Blair IA, Wang QQ, Mesaros C, Snyder N, Boesch S, Chin M, Delatycki MB, Giunti P, Goldsberry A, Hoyle C, McBride MG, Nachbauer W, O'Grady M, Perlman S, Subramony SH, Wilmot GR, Zesiewicz T, Meyer C.

Ann Clin Transl Neurol. 2018 Nov 10;6(1):15-26. doi: 10.1002/acn3.660. eCollection 2019 Jan.

6.

SYNE1-ataxia: Novel genotypic and phenotypic findings.

Indelicato E, Nachbauer W, Fauth C, Krabichler B, Schossig A, Eigentler A, Dichtl W, Wenning G, Wagner M, Fanciulli A, Janecke A, Boesch S.

Parkinsonism Relat Disord. 2019 May;62:210-214. doi: 10.1016/j.parkreldis.2018.12.007. Epub 2018 Dec 11.

PMID:
30573412
7.

Periodontal Ehlers-Danlos syndrome is associated with leukoencephalopathy.

Kapferer-Seebacher I, Waisfisz Q, Boesch S, Bronk M, van Tintelen P, Gizewski ER, Groebner R, Zschocke J, van der Knaap MS.

Neurogenetics. 2019 Mar;20(1):1-8. doi: 10.1007/s10048-018-0560-x. Epub 2018 Dec 8.

8.

Intraepidermal Nerve Fiber Density in Friedreich's Ataxia.

Indelicato E, Nachbauer W, Eigentler A, Rudzki D, Wanschitz J, Boesch S.

J Neuropathol Exp Neurol. 2018 Dec 1;77(12):1137-1143. doi: 10.1093/jnen/nly100.

PMID:
30358880
9.

KMT2B Is Selectively Required for Neuronal Transdifferentiation, and Its Loss Exposes Dystonia Candidate Genes.

Barbagiovanni G, Germain PL, Zech M, Atashpaz S, Lo Riso P, D'Antonio-Chronowska A, Tenderini E, Caiazzo M, Boesch S, Jech R, Haslinger B, Broccoli V, Stewart AF, Winkelmann J, Testa G.

Cell Rep. 2018 Oct 23;25(4):988-1001. doi: 10.1016/j.celrep.2018.09.067.

10.

Nonataxia symptoms in Friedreich Ataxia: Report from the Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS).

Reetz K, Dogan I, Hohenfeld C, Didszun C, Giunti P, Mariotti C, Durr A, Boesch S, Klopstock T, Rodríguez de Rivera Garrido FJ, Schöls L, Giordano I, Bürk K, Pandolfo M, Schulz JB; EFACTS Study Group.

Neurology. 2018 Sep 4;91(10):e917-e930. doi: 10.1212/WNL.0000000000006121. Epub 2018 Aug 10.

PMID:
30097477
11.

The neuropsychiatric phenotype in CACNA1A mutations: a retrospective single center study and review of the literature.

Indelicato E, Nachbauer W, Karner E, Eigentler A, Wagner M, Unterberger I, Poewe W, Delazer M, Boesch S.

Eur J Neurol. 2019 Jan;26(1):66-e7. doi: 10.1111/ene.13765. Epub 2018 Sep 3.

PMID:
30063100
12.

Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias.

Jacobi H, du Montcel ST, Bauer P, Giunti P, Cook A, Labrum R, Parkinson MH, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Sarro L, Rakowicz M, Sulek A, Sobanska A, Schmitz-Hübsch T, Schöls L, Hengel H, Baliko L, Melegh B, Filla A, Antenora A, Infante J, Berciano J, van de Warrenburg BP, Timmann D, Szymanski S, Boesch S, Nachbauer W, Kang JS, Pandolfo M, Schulz JB, Melac AT, Diallo A, Klockgether T.

J Neurol. 2018 Sep;265(9):2040-2051. doi: 10.1007/s00415-018-8954-0. Epub 2018 Jun 29.

PMID:
29959555
13.

Autonomic function testing in Friedreich's ataxia.

Indelicato E, Fanciulli A, Ndayisaba JP, Nachbauer W, Eigentler A, Granata R, Wanschitz J, Poewe W, Wenning GK, Boesch S.

J Neurol. 2018 Sep;265(9):2015-2022. doi: 10.1007/s00415-018-8946-0. Epub 2018 Jun 27.

14.

Sensor-based gait analysis in atypical parkinsonian disorders.

Raccagni C, Gaßner H, Eschlboeck S, Boesch S, Krismer F, Seppi K, Poewe W, Eskofier BM, Winkler J, Wenning G, Klucken J.

Brain Behav. 2018 Jun;8(6):e00977. doi: 10.1002/brb3.977. Epub 2018 May 7.

15.

Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study.

Diallo A, Jacobi H, Cook A, Labrum R, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Rakowicz M, Sobanska A, Sulek A, Schmitz-Hübsch T, Schöls L, Hengel H, Melegh B, Filla A, Antenora A, Infante J, Berciano J, van de Warrenburg BP, Timmann D, Boesch S, Pandolfo M, Schulz JB, Bauer P, Giunti P, Kang JS, Klockgether T, Tezenas du Montcel S.

Lancet Neurol. 2018 Apr;17(4):327-334. doi: 10.1016/S1474-4422(18)30042-5. Epub 2018 Mar 13.

PMID:
29553382
16.

Autonomic function testing in spinocerebellar ataxia type 2.

Indelicato E, Fanciulli A, Ndayisaba JP, Nachbauer W, Granata R, Wanschitz J, Wagner M, Gizewski ER, Poewe W, Wenning GK, Boesch S.

Clin Auton Res. 2018 Jun;28(3):341-346. doi: 10.1007/s10286-018-0504-4. Epub 2018 Feb 12.

17.

Friedreich and dominant ataxias: quantitative differences in cerebellar dysfunction measurements.

Tanguy Melac A, Mariotti C, Filipovic Pierucci A, Giunti P, Arpa J, Boesch S, Klopstock T, Müller Vom Hagen J, Klockgether T, Bürk K, Schulz JB, Reetz K, Pandolfo M, Durr A, Tezenas du Montcel S; EFACTS group.

J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):559-565. doi: 10.1136/jnnp-2017-316964. Epub 2017 Dec 26.

PMID:
29279305
18.

SOX5-Null Heterozygous Mutation in a Family with Adult-Onset Hyperkinesia and Behavioral Abnormalities.

Zech M, Poustka K, Boesch S, Berutti R, Strom TM, Grisold W, Poewe W, Winkelmann J.

Case Rep Genet. 2017;2017:2721615. doi: 10.1155/2017/2721615. Epub 2017 Oct 29.

19.

Bicistronic CACNA1A Gene Expression in Neurons Derived from Spinocerebellar Ataxia Type 6 Patient-Induced Pluripotent Stem Cells.

Bavassano C, Eigentler A, Stanika R, Obermair GJ, Boesch S, Dechant G, Nat R.

Stem Cells Dev. 2017 Nov 15;26(22):1612-1625. doi: 10.1089/scd.2017.0085. Epub 2017 Oct 30.

20.

Ten years of follow-up in a large family with familial hemiplegic migraine type 1: Clinical course and implications for treatment.

Indelicato E, Nachbauer W, Eigentler A, Donnemiller E, Wagner M, Unterberger I, Boesch S.

Cephalalgia. 2018 May;38(6):1167-1176. doi: 10.1177/0333102417715229. Epub 2017 Aug 31.

PMID:
28856914
21.

Molecular diversity of combined and complex dystonia: insights from diagnostic exome sequencing.

Zech M, Jech R, Wagner M, Mantel T, Boesch S, Nocker M, Jochim A, Berutti R, Havránková P, Fečíková A, Kemlink D, Roth J, Strom TM, Poewe W, Růžička E, Haslinger B, Winkelmann J.

Neurogenetics. 2017 Dec;18(4):195-205. doi: 10.1007/s10048-017-0521-9. Epub 2017 Aug 28.

PMID:
28849312
22.

Clinical and genetic characteristics of sporadic adult-onset degenerative ataxia.

Giordano I, Harmuth F, Jacobi H, Paap B, Vielhaber S, Machts J, Schöls L, Synofzik M, Sturm M, Tallaksen C, Wedding IM, Boesch S, Eigentler A, van de Warrenburg B, van Gaalen J, Kamm C, Dudesek A, Kang JS, Timmann D, Silvestri G, Masciullo M, Klopstock T, Neuhofer C, Ganos C, Filla A, Bauer P, Tezenas du Montcel S, Klockgether T.

Neurology. 2017 Sep 5;89(10):1043-1049. doi: 10.1212/WNL.0000000000004311. Epub 2017 Aug 9.

PMID:
28794257
23.

Body Mass Index Decline Is Related to Spinocerebellar Ataxia Disease Progression.

Diallo A, Jacobi H, Schmitz-Hübsch T, Cook A, Labrum R, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Rakowicz M, Sobanska A, Sulek A, Schöls L, Hengel H, Melegh B, Filla A, Antenora A, Infante J, Berciano J, van de Warrenburg BP, Timmann D, Boesch S, Pandolfo M, Schulz JB, Bauer P, Giunti P, Baliko L, Parkinson MH, Kang JS, Klockgether T, Tezenas du Montcel S.

Mov Disord Clin Pract. 2017 Aug 11;4(5):689-697. doi: 10.1002/mdc3.12522. eCollection 2017 Sep-Oct.

24.

Very late-onset pure autonomic failure.

Fanciulli A, Stefanova N, Scherfler C, Moser P, Seppi K, Gizewski ER, Virgolini I, Boesch S, Poewe W, Wenning GK.

Mov Disord. 2017 Jul;32(7):1106-1108. doi: 10.1002/mds.27020. Epub 2017 Apr 24. No abstract available.

25.

Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism.

Krismer F, Pinter B, Mueller C, Mahlknecht P, Nocker M, Reiter E, Djamshidian-Tehrani A, Boesch SM, Wenning GK, Scherfler C, Poewe W, Seppi K.

Parkinsonism Relat Disord. 2017 Feb;35:36-41. doi: 10.1016/j.parkreldis.2016.11.010. Epub 2016 Nov 21.

PMID:
27890451
26.

Haploinsufficiency of KMT2B, Encoding the Lysine-Specific Histone Methyltransferase 2B, Results in Early-Onset Generalized Dystonia.

Zech M, Boesch S, Maier EM, Borggraefe I, Vill K, Laccone F, Pilshofer V, Ceballos-Baumann A, Alhaddad B, Berutti R, Poewe W, Haack TB, Haslinger B, Strom TM, Winkelmann J.

Am J Hum Genet. 2016 Dec 1;99(6):1377-1387. doi: 10.1016/j.ajhg.2016.10.010. Epub 2016 Nov 10.

27.

Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study.

Reetz K, Dogan I, Hilgers RD, Giunti P, Mariotti C, Durr A, Boesch S, Klopstock T, de Rivera FJR, Schöls L, Klockgether T, Bürk K, Rai M, Pandolfo M, Schulz JB; EFACTS Study Group.

Lancet Neurol. 2016 Dec;15(13):1346-1354. doi: 10.1016/S1474-4422(16)30287-3. Erratum in: Lancet Neurol. 2017 Dec;16(12 ):954.

PMID:
27839651
28.

Topography of Dopamine Transporter Availability in the Cerebellar Variant of Multiple System Atrophy.

Nocker M, Seppi K, Boesch S, Donnemiller E, Virgolini I, Wenning GK, Poewe W, Scherfler C.

Mov Disord Clin Pract. 2016 Nov 2;4(3):389-396. doi: 10.1002/mdc3.12446. eCollection 2017 May-Jun.

29.

Clinical exome sequencing in early-onset generalized dystonia and large-scale resequencing follow-up.

Zech M, Boesch S, Jochim A, Weber S, Meindl T, Schormair B, Wieland T, Lunetta C, Sansone V, Messner M, Mueller J, Ceballos-Baumann A, Strom TM, Colombo R, Poewe W, Haslinger B, Winkelmann J.

Mov Disord. 2017 Apr;32(4):549-559. doi: 10.1002/mds.26808. Epub 2016 Sep 26.

PMID:
27666935
30.

Systematic TOR1A non-c.907_909delGAG variant analysis in isolated dystonia and controls.

Zech M, Jochim A, Boesch S, Weber S, Meindl T, Peters A, Gieger C, Mueller J, Messner M, Ceballos-Baumann A, Poewe W, Haslinger B, Winkelmann J.

Parkinsonism Relat Disord. 2016 Oct;31:119-123. doi: 10.1016/j.parkreldis.2016.07.013. Epub 2016 Jul 25.

PMID:
27477622
31.

Standardized Assessment of Hereditary Ataxia Patients in Clinical Studies.

Paap BK, Roeske S, Durr A, Schöls L, Ashizawa T, Boesch S, Bunn LM, Delatycki MB, Giunti P, Lehéricy S, Mariotti C, Melegh J, Pandolfo M, Tallaksen CME, Timmann D, Tsuji S, Schulz JB, van de Warrenburg BP, Klockgether T.

Mov Disord Clin Pract. 2016 Feb 11;3(3):230-240. doi: 10.1002/mdc3.12315. eCollection 2016 May-Jun. Review.

32.

[Memantine for optic nerve atrophy in Friedreich's Ataxia].

Peter S, Manousaridis K, Boesch S, Mennel S.

Ophthalmologe. 2016 Aug;113(8):704-7. doi: 10.1007/s00347-015-0191-7. German.

PMID:
26666888
33.

TOR1A, THAP1, and GNAL mutational screening in Austrian patients with primary isolated dystonia.

Zech M, Boesch S, Sycha T, Mueller J, Poewe W, Winkelmann J.

Mov Disord. 2015 Nov;30(13):1853-4. doi: 10.1002/mds.26458. Epub 2015 Oct 28. No abstract available.

PMID:
26506956
34.

Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.

Jacobi H, du Montcel ST, Bauer P, Giunti P, Cook A, Labrum R, Parkinson MH, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Rakowicz M, Sulek A, Sobanska A, Schmitz-Hübsch T, Schöls L, Hengel H, Baliko L, Melegh B, Filla A, Antenora A, Infante J, Berciano J, van de Warrenburg BP, Timmann D, Szymanski S, Boesch S, Kang JS, Pandolfo M, Schulz JB, Molho S, Diallo A, Klockgether T.

Lancet Neurol. 2015 Nov;14(11):1101-8. doi: 10.1016/S1474-4422(15)00202-1. Epub 2015 Sep 13.

PMID:
26377379
35.

Large-scale TUBB4A mutational screening in isolated dystonia and controls.

Zech M, Boesch S, Jochim A, Graf S, Lichtner P, Peters A, Gieger C, Mueller J, Poewe W, Haslinger B, Winkelmann J.

Parkinsonism Relat Disord. 2015 Oct;21(10):1278-81. doi: 10.1016/j.parkreldis.2015.08.017. Epub 2015 Aug 20.

PMID:
26318963
36.

Acquired ataxias: the clinical spectrum, diagnosis and management.

Nachbauer W, Eigentler A, Boesch S.

J Neurol. 2015 May;262(5):1385-93. doi: 10.1007/s00415-015-7685-8. Epub 2015 Mar 26. Review.

PMID:
25808499
37.

Quantifiable evaluation of cerebellar signs in children.

Filipovic Pierucci A, Mariotti C, Panzeri M, Giunti P, Boesch S, Schulz JB, Pandolfo M, Durr A, Tezenas du Montcel S; EFACTS Study Group.

Neurology. 2015 Mar 24;84(12):1225-32. doi: 10.1212/WNL.0000000000001403. Epub 2015 Feb 25.

PMID:
25716360
38.

Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data.

Reetz K, Dogan I, Costa AS, Dafotakis M, Fedosov K, Giunti P, Parkinson MH, Sweeney MG, Mariotti C, Panzeri M, Nanetti L, Arpa J, Sanz-Gallego I, Durr A, Charles P, Boesch S, Nachbauer W, Klopstock T, Karin I, Depondt C, vom Hagen JM, Schöls L, Giordano IA, Klockgether T, Bürk K, Pandolfo M, Schulz JB.

Lancet Neurol. 2015 Feb;14(2):174-82. doi: 10.1016/S1474-4422(14)70321-7. Epub 2015 Jan 5.

PMID:
25566998
39.

A longitudinal VBM study monitoring treatment with erythropoietin in patients with Friedreich ataxia.

Santner W, Schocke M, Boesch S, Nachbauer W, Egger K.

Acta Radiol Short Rep. 2014 May 12;3(4):2047981614531573. doi: 10.1177/2047981614531573. eCollection 2014 May.

40.

Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes.

Tezenas du Montcel S, Durr A, Bauer P, Figueroa KP, Ichikawa Y, Brussino A, Forlani S, Rakowicz M, Schöls L, Mariotti C, van de Warrenburg BP, Orsi L, Giunti P, Filla A, Szymanski S, Klockgether T, Berciano J, Pandolfo M, Boesch S, Melegh B, Timmann D, Mandich P, Camuzat A; Clinical Research Consortium for Spinocerebellar Ataxia (CRC-SCA); EUROSCA network, Goto J, Ashizawa T, Cazeneuve C, Tsuji S, Pulst SM, Brusco A, Riess O, Brice A, Stevanin G.

Brain. 2014 Sep;137(Pt 9):2444-55. doi: 10.1093/brain/awu174. Epub 2014 Jun 26.

41.

Low bone mineral density in Friedreich ataxia.

Eigentler A, Nachbauer W, Donnemiller E, Poewe W, Gasser RW, Boesch S.

Cerebellum. 2014 Oct;13(5):549-57. doi: 10.1007/s12311-014-0568-1.

PMID:
24858524
42.

Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6.

Tezenas du Montcel S, Durr A, Rakowicz M, Nanetti L, Charles P, Sulek A, Mariotti C, Rola R, Schols L, Bauer P, Dufaure-Garé I, Jacobi H, Forlani S, Schmitz-Hübsch T, Filla A, Timmann D, van de Warrenburg BP, Marelli C, Kang JS, Giunti P, Cook A, Baliko L, Melegh B, Boesch S, Szymanski S, Berciano J, Infante J, Buerk K, Masciullo M, Di Fabio R, Depondt C, Ratka S, Stevanin G, Klockgether T, Brice A, Golmard JL.

J Med Genet. 2014 Jul;51(7):479-86. doi: 10.1136/jmedgenet-2013-102200. Epub 2014 Apr 29. Erratum in: J Med Genet. 2014 Sep;51(9):613. Bela, Melegh [corrected to Melegh, Béla].

43.

Episodic ataxia type 2: phenotype characteristics of a novel CACNA1A mutation and review of the literature.

Nachbauer W, Nocker M, Karner E, Stankovic I, Unterberger I, Eigentler A, Schneider R, Poewe W, Delazer M, Boesch S.

J Neurol. 2014 May;261(5):983-91. Review.

PMID:
24658662
44.

Safety and tolerability of carbamylated erythropoietin in Friedreich's ataxia.

Boesch S, Nachbauer W, Mariotti C, Sacca F, Filla A, Klockgether T, Klopstock T, Schöls L, Jacobi H, Büchner B, vom Hagen JM, Nanetti L, Manicom K.

Mov Disord. 2014 Jun;29(7):935-9. doi: 10.1002/mds.25836. Epub 2014 Feb 11.

PMID:
24515352
45.

EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood.

van de Warrenburg BP, van Gaalen J, Boesch S, Burgunder JM, Dürr A, Giunti P, Klockgether T, Mariotti C, Pandolfo M, Riess O.

Eur J Neurol. 2014 Apr;21(4):552-62. doi: 10.1111/ene.12341. Epub 2014 Jan 13.

PMID:
24418350
46.

Consensus paper: management of degenerative cerebellar disorders.

Ilg W, Bastian AJ, Boesch S, Burciu RG, Celnik P, Claaßen J, Feil K, Kalla R, Miyai I, Nachbauer W, Schöls L, Strupp M, Synofzik M, Teufel J, Timmann D.

Cerebellum. 2014 Apr;13(2):248-68. doi: 10.1007/s12311-013-0531-6.

47.

White matter changes in patients with friedreich ataxia after treatment with erythropoietin.

Egger K, Clemm von Hohenberg C, Schocke MF, Guttmann CR, Wassermann D, Wigand MC, Nachbauer W, Kremser C, Sturm B, Scheiber-Mojdehkar B, Kubicki M, Shenton ME, Boesch S.

J Neuroimaging. 2014 Sep-Oct;24(5):504-8. doi: 10.1111/jon.12050. Epub 2013 Sep 9.

48.

Friedreich ataxia: executive control is related to disease onset and GAA repeat length.

Nachbauer W, Bodner T, Boesch S, Karner E, Eigentler A, Neier L, Benke T, Delazer M.

Cerebellum. 2014 Feb;13(1):9-16. doi: 10.1007/s12311-013-0513-8.

PMID:
23925595
49.

Bioenergetics of the calf muscle in Friedreich ataxia patients measured by 31P-MRS before and after treatment with recombinant human erythropoietin.

Nachbauer W, Boesch S, Schneider R, Eigentler A, Wanschitz J, Poewe W, Schocke M.

PLoS One. 2013 Jul 29;8(7):e69229. doi: 10.1371/journal.pone.0069229. Print 2013.

50.

Induced pluripotent stem cells from friedreich ataxia patients fail to upregulate frataxin during in vitro differentiation to peripheral sensory neurons.

Eigentler A, Boesch S, Schneider R, Dechant G, Nat R.

Stem Cells Dev. 2013 Dec 15;22(24):3271-82. doi: 10.1089/scd.2013.0126. Epub 2013 Aug 24.

PMID:
23879205

Supplemental Content

Loading ...
Support Center